Clinical efficacy of endoscopic debridement combined with compression suture in the treatment of recalcitrant aseptic olecranon bursitis.
Aseptic olecranon bursitis
Efficacy
Elbow
Endoscope
Suture
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
28 Sep 2024
28 Sep 2024
Historique:
received:
14
08
2024
accepted:
17
09
2024
medline:
29
9
2024
pubmed:
29
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
To investigate the clinical efficacy of endoscopic debridement combined with compression suture in the treatment of aseptic olecranon bursitis. A retrospective analysis was conducted on 28 patients, including 25 males and 3 females, who underwent endoscopic debridement combined with compression suture for the treatment of aseptic olecranon bursitis at Huzhou Central Hospital from February 2017 to January 2024. Visual analogue scale (VAS) scores, Mayo elbow function scores, complications, recurrence rates and wound scars were evaluated to assess the treatment efficacy. The average follow-up time was 12 ± 5 months (range: 5-22 months). The VAS score was slightly greater on postoperative day 1 than preoperatively, but this difference was not statistically significant. Compared with the preoperative level, the VAS score was significantly lower at 2 weeks post-surgery, and the patients were generally free of pain. The patients' Mayo elbow function score was significantly improved at 2 weeks after the operation, and their elbow function was generally normal at 1 month after the operation. At the final follow-up, no recurrence or obvious scarring was found in any of the patients, and all of them exhibited normal elbow function without any reported pain. Endoscopic debridement combined with compression suture for the treatment of aseptic olecranon bursitis has several advantages: simple operation, minimal invasiveness, minimal postoperative pain, rapid recovery, a low recurrence rate, and satisfactory overall efficacy. Level of evidence Level IV.
Identifiants
pubmed: 39342360
doi: 10.1186/s13018-024-05090-3
pii: 10.1186/s13018-024-05090-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
596Subventions
Organisme : Zhejiang Youth Innovative Talents Support Program
ID : 2021RC128
Organisme : South Taihu Lake Excellent Young Health Talent Cultivation Program
ID : rsk2023001
Informations de copyright
© 2024. The Author(s).
Références
Nchinda NN, Wolf JM. Clinical management of olecranon bursitis: a review. J Hand Surg Am. 2021;46(6):501–6.
doi: 10.1016/j.jhsa.2021.02.006
pubmed: 33840568
Sayegh ET, Strauch RJ. Treatment of olecranon bursitis: a systematic review. Arch Orthop Trauma Surg. 2014;134(11):1517–36.
doi: 10.1007/s00402-014-2088-3
pubmed: 25234151
Meric G, Sargin S, Atik A, Budeyri A, Ulusal AE. Endoscopic versus open bursectomy for prepatellar and olecranon bursitis. Cureus. 2018;10(3):e2374.
pubmed: 29805943
pmcid: 5969792
Meade TC, Briones MS, Fosnaugh AW, Daily JM. Surgical outcomes in endoscopic versus open bursectomy of the septic prepatellar or olecranon bursa. Orthopedics. 2019;42(4):e381–4.
doi: 10.3928/01477447-20190321-04
pubmed: 30913297
Schöbel T, Hantusch G, Hennings R, Schleifenbaum S, Kleber C, Spiegl U. Risk factors for revision surgery in operative treatment of traumatic injuries of the olecranon and prepatellar bursa. BMC Musculoskelet Disord. 2022;23(1):1008.
doi: 10.1186/s12891-022-05980-9
pubmed: 36419124
pmcid: 9685846
Germawi L, Westenberg RF, Wang F, Schep NWL, Chen NC, Eberlin KR. Factors associated with revision surgery for olecranon bursitis after bursectomy. J Shoulder Elbow Surg. 2021;30(5):1135–41.
doi: 10.1016/j.jse.2020.09.033
pubmed: 33144225
Del Buono A, Franceschi F, Palumbo A, Denaro V, Maffulli N. Diagnosis and management of olecranon bursitis. Surgeon. 2012;10(5):297–300.
doi: 10.1016/j.surge.2012.02.002
pubmed: 22503398
Jensen J, Vavken P. Evidence-based treatment and differential diagnoses of olecranon bursitis. Praxis. 2022;111(12):682–6.
doi: 10.1024/1661-8157/a003889
pubmed: 36102022
Kaur IP, Mughal MS, Aslam F, Schram J, Bansal P. Non-surgical treatment of aseptic olecranon bursitis: a systematic review. Reumatol Clin (Engl Ed). 2023;19(9):482–7.
doi: 10.1016/j.reuma.2023.02.006
pubmed: 37945181
Pohl NB, Brush PL, Toci GR, Heinle JT, Thomas A, Hornstein J, Aita D, Beredjiklian P, Katt B, Fletcher D. Clinical outcomes following open olecranon bursa excision for septic and aseptic olecranon bursitis: an observational study. Cureus. 2023;15(8):e43696.
pubmed: 37724223
pmcid: 10505354
Degreef I, De Smet L. Complications following resection of the olecranon bursa. Acta Orthop Belg. 2006;72(4):400–3.
pubmed: 17009818
Simpson JR, Fagerberg A, Toledo R, Joyner PW. No wound healing complications or recurrences were seen and a high level of satisfaction was reported in patients who underwent endoscopic olecranon bursectomy for recalcitrant olecranon bursitis. Arthrosc Sports Med Rehabil. 2024;6(1):100832.
doi: 10.1016/j.asmr.2023.100832
pubmed: 38299046
pmcid: 10827581
Simpson J, Peters C, Knapp T, Joyner PW. Endoscopic olecranon bursectomy in the treatment of recalcitrant olecranon bursitis: patient selection and operative technique. Arthrosc Tech. 2024;13(1):102828.
doi: 10.1016/j.eats.2023.09.004
pubmed: 38312871
Tu CG, McGuire DT, Morse LP, Bain GI. Olecranon extrabursal endoscopic bursectomy. Tech Hand Up Extrem Surg. 2013;17(3):173–5.
doi: 10.1097/BTH.0b013e31829c0535
pubmed: 23970201
Rhyou IH, Park KJ, Kim KC, Lee JH, Kim SY. Endoscopic olecranon bursal resection for olecranon bursitis: a comparative study for septic and aseptic olecranon bursitis. J Hand Surg Asian Pac. 2016;21(2):167–72.
doi: 10.1142/S2424835516500156